A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer-Reference-Cited by-同舟云学术

A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer

Published:2006-02 Issue:2 Volume:17 Page:239-245
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Twelves C.,Gollins S.,Grieve R.,Samuel L.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/17/2/239/391325/mdj023.pdf

Reference31 articles.

1. Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer;Hansen;J Natl Cancer Inst,1996

2. Complications of an implantable venous access device (Port-a-Cath) during intermittent continuous infusion of chemotherapy;Poorter;Eur J Cancer,1996

3. Transcutaneously tunneled central venous lines in cancer patients: an analysis of device-related morbidity factors based on prospective data collection;Schwarz;Ann Surg Oncol,2000

4. Ionic implantation of silicone chronic venous access devices does not alter thrombotic complications: a double-blinded;Frank;randomized clinical trial. Surgery,2001

5. Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems;Hartkamp;Neth J Med,2000

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Key aspects of medication adherence to oral anticancer drugs: A literature review;Meditsinskiy sovet = Medical Council;2024-01-17

2. The impact of clinical and translational research on the quality of life during the metastatic colorectal cancer patient journey;Frontiers in Oncology;2023-10-16

3. Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems;Nature Reviews Drug Discovery;2023-03-27

4. Predictors of community pharmacists’ readiness to manage the effective and safe use of oral anticancer medicines in a developing setting;Journal of Oncology Pharmacy Practice;2022-11-25

5. Improving the efficiency of the medicine provision system for patients with malignant neoplasms;FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology;2022-07-27